Risk factors for new-onset chronic kidney disease in patients who have received a liver transplant

被引:13
作者
Li, Yuehong [1 ]
Li, Binbin [1 ]
Wang, Wei [1 ]
Lv, Jiaxuan [1 ]
机构
[1] Tsinghua Univ, Sch Clin Med, Dept Nephrol, Beijing Tsinghua Changgung Hosp, 168 Litang Rd, Beijing 102218, Peoples R China
关键词
calcineurin inhibitors; chronic kidney disease; liver transplantation; renal pathology; STAGE RENAL-DISEASE; CALCINEURIN-INHIBITORS; DYSFUNCTION; RECIPIENTS;
D O I
10.3892/etm.2018.5823
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of the present study was to analyze the risk factors for new-onset chronic kidney disease (CKD) in patients who have received a liver transplant. A total of 190 patients who underwent liver transplantation between March 2001 and January 2015 were followed up, and analyzed retrospectively. Sex, age, primary disease, preoperative laboratory findings (hemoglobin, albumin, creatinine and glomerular filtration rate), surgical approach, blood loss during the surgery and transfusion volume, postoperative complications, and the average levels of calcineurin inhibitors (CNIs) (from liver transplantation to the onset of CKD) were analyzed. In total, 40 patients developed new-onset CKD after transplantation. Clinical data in the new-onset CKD group were compared with the non-CKD group. A 2 test, t-test and logistic regression analysis were performed using SPSS 17.0 software. The incidence of new-onset CKD after liver transplantation was 21.1%. Renal pathology included IgA nephropathy, hepatitis B virus-associated nephropathy, membranous proliferative glomerulonephritis, focal segmental glomerular sclerosis and cryoglobulinemia-associated renal injury. Among the CKD patients, 85.7% had tubulointerstitial damage. Univariate analysis showed that preoperative renal function, hemoglobin, intraoperative blood loss and transfusion volume, postoperative acute kidney injury, average levels of CNIs, and hypertension were risk factors for new-onset CKD after liver transplantation. Logistic regression analysis showed that preoperative glomerular filtration rate [odds ratio (OR)=0.980, P=0.041], hemoglobin (OR=0.972, P=0.034), average levels of CNIs (OR=1.364, P=0.015) and hypertension (OR=4.833, P=0.048)] were independent risk factors for new-onset CKD. The incidence of new-onset CKD in patients who received liver transplantation was high. The main risk factors were identified to be preoperative glomerular filtration rate, hemoglobin, postoperative average levels of CNIs and hypertension.
引用
收藏
页码:3589 / 3595
页数:7
相关论文
共 50 条
[21]   NEW-ONSET DIABETES AFTER KIDNEY TRANSPLANTATION: DIAGNOSIS, RISK FACTORS, AND MANAGEMENT [J].
Bulum, Tomislav ;
Prkacin, Ingrid ;
Duvnjak, Lea .
ACTA CLINICA CROATICA, 2021, 60 :86-95
[22]   Association of changes in metabolic syndrome with new-onset and progression of chronic kidney disease [J].
Zhao, Naihui ;
Zhang, Yinggen ;
Liu, Peipei ;
Zhang, Xiaofu ;
Zhang, Zihao ;
Ou, Wenli ;
Dong, Ao ;
Chang, Yanhe ;
Chen, Shuohua ;
Wang, Guodong ;
Wu, Shouling ;
Yang, Xiuhong .
ENDOCRINE, 2025, 88 (01) :99-109
[23]   Relations of residential green and blue spaces with new-onset chronic kidney disease [J].
Liu, Mengyi ;
Ye, Ziliang ;
He, Panpan ;
Yang, Sisi ;
Zhang, Yanjun ;
Zhou, Chun ;
Zhang, Yuanyuan ;
Gan, Xiaoqin ;
Qin, Xianhui .
SCIENCE OF THE TOTAL ENVIRONMENT, 2023, 869
[24]   Pre-transplant Kidney Function Predicts Chronic Kidney Disease After Liver Transplant: Meta-Analysis of Observational Studies [J].
Fabrizi, Fabrizio ;
Dixit, Vivek ;
Martin, Paul ;
Messa, Piergiorgio .
DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (05) :1282-1289
[25]   Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes [J].
Filippatos, Gerasimos ;
Bakris, George L. ;
Pitt, Bertram ;
Agarwal, Rajiv ;
Rossing, Peter ;
Ruilope, Luis M. ;
Butler, Javed ;
Lam, Carolyn S. P. ;
Kolkhof, Peter ;
Roberts, Luke ;
Tasto, Christoph ;
Joseph, Amer ;
Anker, Stefan D. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (02) :142-152
[26]   Role of Metformin in Preventing New-Onset Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus [J].
Lin, Yu-Ling ;
Lin, Sheng-Hsiang ;
Wang, Hsi-Hao ;
Hsu, Wan-Chia ;
Hung, Shih-Yuan ;
Chiou, Yuan-Yow ;
Liou, Hung-Hsiang ;
Chang, Min-Yu ;
Ho, Li-Chun ;
Wu, Ching-Fang ;
Lee, Yi-Che .
PHARMACEUTICALS, 2025, 18 (01)
[27]   An Analysis of the Risk Factors for New-Onset Diabetes Mellitus After Liver Transplantation [J].
Sun, Jushan ;
He, Yibiao ;
Bai, Lei ;
Wang, Zhipeng ;
Cao, Zhu ;
Shao, Yingmei ;
Zhao, Jinming .
INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 :4783-4792
[28]   Regression of new-onset diabetes mellitus after conversion from tacrolimus to cyclosporine in liver transplant patients: Results of a pilot study [J].
Lorho, R. ;
Hardwigsen, J. ;
Dumortier, J. ;
Pageaux, G. -P. ;
Durand, F. ;
Bizollon, T. ;
Blanc, A. -S. ;
Di Giambattista, F. ;
Duvoux, C. .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2011, 35 (6-7) :482-488
[29]   Anemia and atrial fibrillation as independent risk factors for new-onset chronic kidney disease: the TAMA-MED Project-CKD and AF [J].
Kaneko, Tomohiro ;
Kodani, Eitaro ;
Fujii, Hitomi ;
Asai, Risa ;
Seki, Miyako ;
Nakazato, Rei ;
Nakamura, Hiroyuki ;
Sasabe, Hajime ;
Tamura, Yutaka .
CLINICAL KIDNEY JOURNAL, 2021, 14 (10) :2221-2226
[30]   Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant [J].
Wong, Germaine ;
Li, Margaret W. Y. ;
Howard, Kirsten ;
Hua, Danny K. ;
Chapman, Jeremy R. ;
Bourke, Michael ;
Turner, Robin ;
Tong, Allison ;
Craig, Jonathan C. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (04) :917-926